Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 84 are a BUY (77.78%), 18 are a HOLD (16.67%), 6 are a SELL (5.56%).
Analyst Whitney Ijem, currently employed at CANACCORD, carries an average stock price target met ratio of 35.4% that have a potential upside of 19.11% achieved within 251 days.
Whitney Ijem’s has documented 212 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PASG, Passage Bio at 14-Aug-2025.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 5/30/2019. The price target of $48 was fulfilled within 48 days with a profit of $16 (50%) receiving and performance score of 10.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$50
$27.36 (120.85%)
$50
16 days ago
(22-Sep-2025)
0/9 (0%)
$31.35 (168.10%)
Buy
$22
$-0.64 (-2.83%)
$98
23 days ago
(15-Sep-2025)
16/25 (64%)
$4.53 (25.93%)
229
Hold
$15
$-7.64 (-33.75%)
$160
29 days ago
(09-Sep-2025)
15/20 (75%)
$-2.64 (-14.97%)
133
Sell
$16
$-6.64 (-29.33%)
$10
1 months 17 days ago
(21-Aug-2025)
4/16 (25%)
$-4.06 (-20.24%)
246
Sell
$12
$-10.64 (-47.00%)
$9
1 months 23 days ago
(15-Aug-2025)
1/9 (11.11%)
$-9.81 (-44.98%)
27
Which stock is Whitney Ijem is most bullish on?
Which stock is Whitney Ijem is most reserved on?
What Year was the first public recommendation made by Whitney Ijem?